Home/Filings/4/0001193125-26-002367
4//SEC Filing

Ferrante Karen Jean 4

Accession 0001193125-26-002367

CIK 0001622229other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:01 PM ET

Size

5.7 KB

Accession

0001193125-26-002367

Insider Transaction Report

Form 4
Period: 2026-01-01
Transactions
  • Award

    Stock Option (Right to Buy)

    2026-01-01+643643 total
    Exercise: $34.74From: 2026-01-01Exp: 2036-01-01Common Stock (643 underlying)
Footnotes (1)
  • [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

Documents

1 file

Issuer

Cogent Biosciences, Inc.

CIK 0001622229

Entity typeother

Related Parties

1
  • filerCIK 0001598502

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:01 PM ET
Size
5.7 KB